Mineralys Therapeutics
(NASDAQ) MLYS
Mineralys Therapeutics Financials at a Glance
Market Cap
$2.23B
Revenue (TTM)
$0.00
Net Income (TTM)
$154.65M
EPS (TTM)
$-2.38
P/E Ratio
-11.39
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$26.41
Volume
43,595
Open
$27.95
Price
$26.41
Volume
43,595
Open
$27.95
Previous Close
$26.41
Daily Range
$26.28 - $29.07
52-Week Range
$10.44 - $47.65
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$26.41
Volume
43,595
Open
$27.95
Previous Close
$26.41
Daily Range
$26.28 - $29.07
52-Week Range
$10.44 - $47.65
MLYS News
MLYS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mineralys Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
76
CEO
Jon Congleton
Website
www.mineralystx.comHeadquarters
Radnor, PA 19087, US
MLYS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-37%
Return on Capital
-26%
Return on Assets
-23%
Earnings Yield
-8.78%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.23B
Shares Outstanding
82.40M
Volume
43.59K
Short Interest
0.00%
Avg. Volume
1.25M
Financials (TTM)
Gross Profit
$59.00K
Operating Income
$170.60M
EBITDA
$170.60M
Operating Cash Flow
$142.42M
Capital Expenditure
$15.00K
Free Cash Flow
$142.43M
Cash & ST Invst.
$656.63M
Total Debt
$0.00
Mineralys Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$13.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.23B
N/A
Market Cap/Employee
$43.77M
N/A
Employees
51
N/A
Net Income
$32.23M
+34.1%
EBITDA
$38.27M
+26.1%
Quarterly Fundamentals
Net Cash
$656.63M
+231.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-23.37%
N/A
Return on Invested Capital
-26.38%
N/A
Free Cash Flow
$37.90M
+43.3%
Operating Cash Flow
$37.89M
+43.3%